India’s first non-surgical treatment for uterine fibroids, MRgFUS opens at Jaslok Hospital
eHEALTH BureauA new facility offering Indian women a major breakthrough treatment for uterine fibroids, a common gynaecological condition, is opening at Jaslok Hospital, Mumbai. The revolutionary new technology – GE Magnetic Resonance-guided Focused Ultrasound surgery (MRgFUS) treats uterine fibroids in women by using high intensity ultrasound waves to non-invasively destroy benign tumours of the uterus. The most common treatment for fibroids is hysterectomy, a surgical procedure that involves a stay in hospital and up to six weeks of recovery time. MRgFUS destroys fibroids without causing damage to surrounding tissues and could be used as a common alternative to removal of a uterus or hysterectomy. The treatment, which is carried out as an outpatient procedure has a short recovery time than hysterectomy and can help women to return much more quickly to normal daily activities.The MRgFUS technology – the ExAblate
post_id:
uld_count:
Cookie not set
Like
Dislike
Value 1: 0
Value 2: 10
